Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis.
作者信息
Callejas Rubio José Luis, Ríos Fernández Raquel, De la Hera Fernández Javier
机构信息
Unidad de Enfermedades Sistémicas, Servicio de Medicina Interna, Hospital Clínico Universitario San Cecilio, Granada, Spain.
出版信息
Med Clin (Engl Ed). 2022 Jan 21;158(2):91-92. doi: 10.1016/j.medcle.2021.05.009. Epub 2021 Dec 25.
Abstract
摘要
相似文献
1
Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis.严重急性呼吸综合征冠状病毒2型疫苗在巨细胞动脉炎患者中的疗效和安全性
Med Clin (Engl Ed). 2022 Jan 21;158(2):91-92. doi: 10.1016/j.medcle.2021.05.009. Epub 2021 Dec 25.
2
Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis.严重急性呼吸综合征冠状病毒2型疫苗在巨细胞动脉炎患者中的疗效和安全性。
Med Clin (Barc). 2022 Jan 21;158(2):91-92. doi: 10.1016/j.medcli.2021.05.003. Epub 2021 May 27.
3
SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150.严重急性呼吸综合征冠状病毒2、风湿性多肌痛和巨细胞动脉炎：新冠疫苗接种会成为诱因吗？对曼佐等人所著《严重急性呼吸综合征冠状病毒2会引发风湿性多肌痛复发吗？》的评论。《关节与脊柱》2021年；88:105150
Joint Bone Spine. 2022 Jan;89(1):105282. doi: 10.1016/j.jbspin.2021.105282. Epub 2021 Sep 29.
4
Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study.在西班牙 COVID-19 大流行期间巨细胞动脉炎和相关卒中发病率增加：一项全国范围内的人群研究。
Autoimmun Rev. 2023 Jun;22(6):103341. doi: 10.1016/j.autrev.2023.103341. Epub 2023 Apr 14.
5
Answer to Cadiou et al. "SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?". Joint Bone Spine 2021;88:105282.对卡迪乌等人《严重急性呼吸综合征冠状病毒2型、风湿性多肌痛和巨细胞动脉炎：新冠疫苗接种是诱因吗？》的回复。《关节与脊柱》2021年；88:105282
Joint Bone Spine. 2022 Jan;89(1):105284. doi: 10.1016/j.jbspin.2021.105284. Epub 2021 Oct 1.
6
Large-vessel giant cell arteritis after COVID-19 vaccine.新冠疫苗接种后发生的大血管巨细胞动脉炎
Scand J Rheumatol. 2022 Mar;51(2):154-155. doi: 10.1080/03009742.2021.1961401. Epub 2021 Sep 28.
7
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial.司库奇尤单抗治疗巨细胞动脉炎患者的安全性和疗效（TitAIN）：一项随机、双盲、安慰剂对照、2 期临床试验。
Lancet Rheumatol. 2023 Jun;5(6):e341-e350. doi: 10.1016/S2665-9913(23)00101-7.
8
Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up study.接种严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）疫苗后的神经自身免疫性疾病：一项随访研究。
Eur J Neurol. 2023 Feb;30(2):463-473. doi: 10.1111/ene.15602. Epub 2022 Nov 2.
9
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort.巨细胞动脉炎患者接种三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗后的体液免疫和T细胞免疫反应：一项前瞻性队列分析
Clin Exp Rheumatol. 2024 Apr;42(4):942. doi: 10.55563/clinexprheumatol/mlatyf. Epub 2023 Sep 15.
10
New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria) Vaccine Administration.接种ChAdOx1-S（Vaxevria）疫苗后新发巨细胞动脉炎
Vaccines (Basel). 2023 Feb 13;11(2):434. doi: 10.3390/vaccines11020434.
引用本文的文献
1
Neurological Adverse Reactions to SARS-CoV-2 Vaccines.新型冠状病毒疫苗的神经不良反应
Clin Psychopharmacol Neurosci. 2023 May 30;21(2):222-239. doi: 10.9758/cpn.2023.21.2.222.
2
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.新冠病毒疫苗在免疫功能低下人群中的免疫和临床疗效：一项系统评价
Clin Microbiol Infect. 2022 Feb;28(2):163-177. doi: 10.1016/j.cmi.2021.09.036. Epub 2021 Nov 17.
3
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases.免疫介导疾病患者接种新型冠状病毒疫苗面临的挑战
Vaccines (Basel). 2021 Oct 8;9(10):1147. doi: 10.3390/vaccines9101147.
本文引用的文献
1
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对单剂SARS-CoV-2 mRNA疫苗的抗体反应。
Ann Rheum Dis. 2021 Aug;80(8):1098-1099. doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.
2
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.美国风湿病学会关于风湿性和肌肉骨骼疾病患者接种新冠病毒疫苗的指南：第1版
Arthritis Rheumatol. 2021 Jul;73(7):1093-1107. doi: 10.1002/art.41734. Epub 2021 May 24.
3
Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective.2019冠状病毒病大流行期间巨细胞动脉炎患者的临床路径：国际视角
Lancet Rheumatol. 2021 Jan;3(1):e71-e82. doi: 10.1016/S2665-9913(20)30386-6. Epub 2020 Dec 8.
4
Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.巨细胞动脉炎和风湿性多肌痛的发病率和患病率：系统文献回顾。
Semin Arthritis Rheum. 2020 Oct;50(5):1040-1048. doi: 10.1016/j.semarthrit.2020.07.005. Epub 2020 Jul 14.
5
Trial of Tocilizumab in Giant-Cell Arteritis.托珠单抗治疗巨细胞动脉炎的临床试验。
N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849.
Zotero 插件